Search Results - "Rokkedal, J."

Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension by Devereux, Richard B, Wachtell, Kristian, Gerdts, Eva, Boman, Kurt, Nieminen, Markku S, Papademetriou, Vasilios, Rokkedal, Jens, Harris, Katherine, Aurup, Peter, Dahlöf, Björn

“…CONTEXT Increased baseline left ventricular (LV) mass predicts cardiovascular (CV) complications of hypertension, but the relation between lower LV mass and…”
Get full text

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial by Devereux, Richard B, Dahlöf, Björn, Gerdts, Eva, Boman, Kurt, Nieminen, Markku S, Papademetriou, Vasilios, Rokkedal, Jens, Harris, Katherine E, Edelman, Jonathan M, Wachtell, Kristian

“…An echocardiographic substudy of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to…”
Get full text

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation : The losartan intervention for end point reduction in hypertension (LIFE) study by WACHTELL, Kristian, HORNESTAM, Björn, KJELDSEN, Sverre E, LINDHOLM, Lars H, NIEMINEN, Markku S, ROKKEDAL, Jens, DEVEREUX, Richard B, LEHTO, Mika, SLOTWINER, David J, GERDTS, Eva, OLSEN, Michael H, AURUP, Peter, DAHLOF, Björn, IBSEN, Hans, JULIUS, Stevo

“…We assessed the impact of antihypertensive treatment in hypertensive patients with electrocardiographic (ECG) left ventricular (LV) hypertrophy and a history…”
Get full text

Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy by OLSEN, M. H, CHRISTENSEN, M. K, DIGE-PETERSEN, H, ROKKEDA, J, IBSEN, H, WACHTELL, K, TUXEN, C, FOSSUM, E, BANG, L. E, WIINBERG, N, DEVEREUX, R. B, KJELDSEN, S. E, HILDEBRANDT, P

“…Cardiac fibrosis and high levels of circulating collagen markers has been associated with left ventricular (LV) hypertrophy. However, the relationship to…”
Get full text

Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy by OLSEN, M. H, WACHTELL, K, MEYER, C, HOVE, J. D, PALMIERI, V, DIGE-PETERSEN, H, ROKKEDAL, J, HESSE, B, IBSEN, H

“…Impaired myocardial flow reserve (MFR) has been demonstrated in hypertension, and has been associated with peripheral vascular changes. We investigated whether…”
Get full text

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study by Wachtell, Kristian, Papademetriou, Vasilios, Smith, Gunnar, Gerdts, Eva, Dahlöf, Björn, Engblom, Erik, Aurigemma, Gerard P., Bella, Jonathan N., Ibsen, Hans, Rokkedal, Jens, Devereux, Richard B.

“…Patients with hypertensive left ventricular (LV) hypertrophy commonly have diastolic dysfunction with preserved LV ejection fraction. LV systolic midwall…”
Get full text

Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study by Devereux, R B, Bella, J, Boman, K, Gerdts, E, Nieminen, M S, Rokkedal, J, Papademetriou, V, Wachtell, K, Wright, J, Paranicas, M, Okin, P M, Roman, M J, Smith, G, Dahlöf, B

“…To assess the prevalence of echocardiographic left ventricular hypertrophy (LVH) and concentric remodeling in hypertensive patients with electrocardiographic…”
Get more information

Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy by Olsen, Michael H, Wachtell, Kristian, Aalkjaer, Christian, Dige-Petersen, Harriet, Rokkedal, Jens, Ibsen, Hans

“…Flow-mediated dilatation (FMD), which is considered a measure of endothelial function, has been found impaired in hypertension. However, it is unclear whether…”
Get full text

Is inappropriate left ventricular mass related to neurohormonal factors and or arterial changes in hypertension? a LIFE substudy by OLSEN, M. H, WACHTELL, K, DE SIMONE, G, PALMIERI, V, DIGE-PETERSEN, H, DEVEREUX, R. B, IBSEN, H, ROKKEDAL, J

“…We investigated whether inappropriately high left ventricular (LV) mass, defined as observed LV mass exceeding the level of individual LV mass predicted from…”
Get full text

24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy by WIINBERG, N, BANG, L. E, WACHTELL, K, LARSEN, J, OLSEN, M. H, TUXEN, C, HILDEBRANDT, P. R, ROKKEDAL, J, IBSEN, H, DEVEREUX, R. B

“…This study was undertaken to evaluate the relationships among left ventricular (LV) geometric patterns and urinary albumin excretion in patients with…”
Get full text

24-hour ambulatory blood pressure in patients with ECG determined left ventricular hypertrophy: the life study by Wiinberg, N, Bang, LE, Wachtell, K, Olsen, M.H., Tuxen, C, Rokkedal, J, Ibsen, H, Devereux, R.B.

Get full text

Left ventricular structure and diastolic function in subjects with two hypertensive parents by Andersen, U B, Steensgaard-Hansen, F, Rokkedal, J, Ibsen, H, Dige-Petersen, H

“…To examine the influence of (i) strong predisposition to essential hypertension and (ii) insulin sensitivity and plasma levels of cardiomyotrophic hormones on…”
Get more information

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial by Dargie, H J, Lechat, P

“…In patients with heart failure, β-blockade has improved morbidity and left-ventricular function, but the impact on survival is uncertain. We investigated the…”
Get full text

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The losartan intervention for endpoint reduction in hypertension (LIFE) study by WACHTELL, Kristian, BELLA, Jonathan N, ROKKEDAL, Jens, PALMIERI, Vittorio, PAPADEMETRIOU, Vasilios, DAHLÖF, Bjorn, AALTO, Tapio, GERDTS, Eva, DEVEREUX, Richard B

“…It is well established that hypertensive patients with left ventricular (LV) hypertrophy have impaired diastolic filling. However, the impact of…”
Get full text

N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study by Olsen, Michael H, Wachtell, Kristian, Tuxen, Christian, Fossum, Eigil, Bang, Lia E, Hall, Christian, Ibsen, Hans, Rokkedal, Jens, Devereux, Richard B, Hildebrandt, Per

“…BACKGROUNDN-terminal pro-brain natriuretic peptide (Nt-proBNP) and N-terminal pro-atrial natriuretic peptide (Nt-proANP) are strong cardiovascular risk markers…”
Get full text

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study by Wachtell, Kristian, Gerdts, Eva, Aurigemma, Gerard P, Boman, Kurt, Dahlöf, Björn, Nieminen, Markku S, Olsen, Michael Hecht, Okin, Peter M, Palmieri, Vittorio, Rokkedal, Jens E, Devereux, Richard B

“…It is unclear whether improvement of left atrial (LA) and ventricular (LV) structure results in reduction in new-onset atrial fibrillation (AF). The aim of the…”
Get more information

Impact of Different Partition Values on Prevalences of Left Ventricular Hypertrophy and Concentric Geometry in a Large Hypertensive Population: The LIFE Study by Wachtell, Kristian, Bella, Jonathan N, Liebson, Philip R, Gerdts, Eva, Dahlöf, Björn, Aalto, Tapio, Roman, Mary J, Papademetriou, Vasilios, Ibsen, Hans, Rokkedal, Jens, Devereux, Richard B

“…Left ventricular (LV) hypertrophy and concentric remodeling have been defined by using a variety of indexation methods and partition values (PVs) for LV mass…”
Get full text

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study) by Wachtell, Kristian, Smith, Gunnar, Gerdts, Eva, Dahlöf, Björn, Nieminen, Markku S, Papademetriou, Vasilios, Bella, Jonathan N, Ibsen, Hans, Rokkedal, Jens, Devereux, Richard B

“…Abnormal left ventricular (LV) filling may exist in early stages of hypertension. Whether this finding is related to LV hypertrophy is currently controversial…”
Get full text

Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy by Olsen, Michael H, Wachtell, Kristian, Tuxen, Christian, Fossum, Eigil, Bang, Lia E, Hall, Christian, Ibsen, Hans, Rokkedal, Jens, Devereux, Richard B, Hildebrandt, Per R

“…BACKGROUNDSecretion of natriuretic peptides is related to cardiac wall stress and influenced by the renin–angiotensin system. Therefore, we investigated the…”
Get full text

Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study by Wachtell, Kristian, Dahlöf, Björn, Rokkedal, Jens, Papademetriou, Vasilious, Nieminen, Markku S., Smith, Gunnar, Gerdts, Eva, Boman, Kurt, Bella, Jonathan N., Devereux, Richard B.

“…Background Patients with hypertension have different types of left ventricular (LV) geometry, but the impact of blood pressure (BP) reduction on LV geometry…”
Get full text